These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35585310)

  • 21. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clusterin: a forgotten player in Alzheimer's disease.
    Nuutinen T; Suuronen T; Kauppinen A; Salminen A
    Brain Res Rev; 2009 Oct; 61(2):89-104. PubMed ID: 19651157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
    DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
    de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
    Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clusterin contributes to early stage of Alzheimer's disease pathogenesis.
    Oh SB; Kim MS; Park S; Son H; Kim SY; Kim MS; Jo DG; Tak E; Lee JY
    Brain Pathol; 2019 Mar; 29(2):217-231. PubMed ID: 30295351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides.
    Leo G; Genedani S; Filaferro M; Carone C; Andreoli N; Astancolle S; Davalli P; Fuxe K; Agnati LF
    Curr Alzheimer Res; 2007 Jul; 4(3):305-13. PubMed ID: 17627488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats.
    Ceyzériat K; Zilli T; Millet P; Koutsouvelis N; Dipasquale G; Fossey C; Cailly T; Fabis F; Frisoni GB; Garibotto V; Tournier BB
    J Neuroinflammation; 2022 Dec; 19(1):311. PubMed ID: 36550510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures.
    Srinivasan R; Marchant RE; Zagorski MG
    Amyloid; 2004 Mar; 11(1):10-3. PubMed ID: 15185493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI).
    Elias AK; Wilson MR; Carver JA; Musgrave IF
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer's disease.
    Qi XM; Wang C; Chu XK; Li G; Ma JF
    BMC Neurosci; 2018 Jan; 19(1):2. PubMed ID: 29370749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzothiazole aniline tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro.
    Chilumuri A; Odell M; Milton NG
    ACS Chem Neurosci; 2013 Nov; 4(11):1501-12. PubMed ID: 23968537
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clusterin and Alzheimer's disease.
    Calero M; Rostagno A; Frangione B; Ghiso J
    Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.
    Endo Y; Hasegawa K; Nomura R; Arishima H; Kikuta KI; Yamashita T; Inoue Y; Ueda M; Ando Y; Wilson MR; Hamano T; Nakamoto Y; Naiki H
    Acta Neuropathol Commun; 2019 Jan; 7(1):12. PubMed ID: 30691533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue.
    Howlett DR; Hortobágyi T; Francis PT
    Brain Pathol; 2013 Nov; 23(6):623-32. PubMed ID: 23521156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and neurotoxicity of novel amyloids derived from the BRI gene.
    Gibson G; El-Agnaf OM; Anwar Z; Sidera C; Isbister A; Austen BM
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1111-2. PubMed ID: 16246057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring Amyloidogenicity of Clusterin: A Structural and Bioinformatics Analysis.
    Tsiolaki PL; Nastou KC; Louros NN; Hamodrakas SJ; Iconomidou VA
    Adv Exp Med Biol; 2017; 989():93-107. PubMed ID: 28971419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.